Sign up
Pharma Capital

Concepta surges on news of UK myLotus launch

Women attending the show will be able to exclusively buy a Starter Pack at a 'Special Launch' price of £199
myLotus tester
myLotus received CE-Mark certification earlier this week

Concepta PLC (LON:CPT) shares surged in lunchtime trading Wednesday after it said it will launch its myLotus product in the UK at the Fertility Show in London, to be held on the 3rd and 4th of November.

The healthcare group said its stand at the show, to be held in Olympia, will also include representation from key opinion leaders, fertility doctors and health experts who will answer questions on myLotus products.

READ: Concepta jumps as myLotus products receive CE-Mark certification

Earlier this week, Concepta said that its myLotus product range, which helps women monitor their fertility levels, had received CE-Mark certification from regulators, allowing its sale in the UK.

Matthew Walls, chairman of Concepta, said women attending the show would be able to exclusively buy a Starter Pack, consisting of a myLotus monitor, 3 packs of 20 ovulation tests and 3 packs of 3 pregnancy tests, at the 'Special Launch' price of £199.

He added that the products would also be made available online.

Shares were up 8.1% at 4p.

-- Adds share price --

View full CPT profile View Profile
View All

Related Articles

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.